Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing

Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing

Fibrotic diseases contribute to 45% of deaths in the industrialized world, and therefore a better understanding of the pathophysiological mechanisms underlying tissue fibrosis is sorely needed. We aimed to identify novel modifiers of tissue fibrosis expressed by myofibroblasts and their progenitors...

Full description

Bibliographic Details
Main Authors: Elisabeth H. Vollmann, Lizhi Cao, Aldo Amatucci, Taylor Reynolds, Stefan Hamann, Isin Dalkilic-Liddle, Thomas O. Cameron, Markus Hossbach, Kevin J. Kauffman, Faryal F. Mir, Daniel G. Anderson, Tatiana Novobrantseva, Victor Koteliansky, Tatiana Kisseleva, David Brenner, Jeremy Duffield, Linda C. Burkly
Format: Article
Language:English
Published: Elsevier 2017-06-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
fibrosis
myofibroblast
siRNA
LNP
in vivo gene silencing
Egr2
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253117301646

Internet

http://www.sciencedirect.com/science/article/pii/S2162253117301646

Similar Items